What is Gulf Pharmaceutical Industries PSC Revenue per Share?
Gulf Pharmaceutical Industries PSC's revenue per share for the
three
months ended in Dec. 2023 was د.إ0.36.
Gulf Pharmaceutical Industries PSC's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ1.42.
Warning Sign:
Gulf Pharmaceutical Industries PSC revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Gulf Pharmaceutical Industries PSC was 1.40% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 37.80% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 19.10% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 2.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Revenue per Share or its related term are showing as below:
ADX:JULPHAR'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -42 Med: 7.2 Max: 149.5
Current: 37.8
During the past 13 years, Gulf Pharmaceutical Industries PSC's highest 3-Year average Revenue Per Share Growth Rate was 149.50% per year. The lowest was -42.00% per year. And the median was 7.20% per year.
ADX:JULPHAR's 3-Year Revenue Growth Rate is ranked better than 91.97% of 922
companies
in the Drug Manufacturers industry
Industry Median: 6.4
vs ADX:JULPHAR: 37.80
Gulf Pharmaceutical Industries PSC Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Gulf Pharmaceutical Industries PSC Revenue per Share Chart
Competitive Comparison of Gulf Pharmaceutical Industries PSC's Revenue per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Pharmaceutical Industries PSC's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gulf Pharmaceutical Industries PSC's PS Ratio falls into.
Gulf Pharmaceutical Industries PSC Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ1.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Gulf Pharmaceutical Industries PSC Revenue per Share Related Terms
Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADX:JULPHAR has been successfully added to your 